Neonatal TPN Starter Bag Recalled Due to Sterility Assurance Issues
Central Admixture Pharmacy Services is recalling a neonatal IV nutrition bag due to lack of sterility assurance. The recall affects 156 bags of the product distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a neonatal parenteral nutrition product. While no illnesses have been reported, the defect—lack of assurance of sterility in a critical care product for vulnerable newborns—constitutes a risk-of-harm scenario meeting the High severity threshold.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling Neonatal TPN Starter Bag (Amino Acids 3.5% / Dextrose 10% with Calcium, 250 mL) with NDC 72196-0407-1 due to lack of assurance of sterility. Validation data for decontamination cycles is lacking.
The affected lot is 36-251206 with an expiration date of July 10, 2023. A total of 156 bags were distributed nationwide.
Neonatal TPN bags are critical care products used for intravenous nutrition in newborns. Lack of sterility assurance poses a potential risk of infection in this vulnerable population. No illnesses have been reported to date.
Healthcare providers who received this product should contact Central Admixture Pharmacy Services, Inc. or the FDA for guidance on appropriate actions regarding the recalled lot.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with CALCIUM, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043,NDC: 72196-0407-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 36-251206
- Exp. 7/10/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27